RFG
DGX icon

RFP Financial Group’s Quest Diagnostics DGX Stock Holding History

RFP Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39
Closed -$5.34K – 280
2024
Q2 		$5.34K Hold
39
– – ﹤0.01% 549
2024
Q1 		$5.19K Sell
39
-22
-36% -$2.85K ﹤0.01% 523
2023
Q4 		$8.41K Buy
61
+25
+69% +$3.29K ﹤0.01% 439
2023
Q3 		$4.39K Hold
36
– – ﹤0.01% 532
2023
Q2 		$5.06K Hold
36
– – ﹤0.01% 548
2023
Q1 		$5.09K Hold
36
– – 0.01% 391
2022
Q4 		$5.63K Buy
+36
New +$5.17K ﹤0.01% 506

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

RFP Financial Group's DGX Position: Q3 2024 in Review

RFP Financial Group sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 39 shares — an estimated $5.34K sold.

RFP Financial Group first reported a position in DGX in Q4 2022 and held it in 7 quarters. The position peaked at $8.41K in Q4 2023. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • RFP Financial Group reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 39 Quest Diagnostics shares in Q3 2024, an estimated $5.34K.
  • RFP Financial Group first reported a position in Quest Diagnostics in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Quest Diagnostics position peaked at $8.41K in Q4 2023.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.